Coastal Investment Advisors, Inc. Editas Medicine, Inc. Transaction History

Coastal Investment Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 16, 2020	SELL	$18.5 - $34.34 $255,577 - $474,407	-13,815 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$14.88 - $32.78 $5,431 - $11,964	-365 Reduced 2.57%	13,815 $274,000
Q4 2019 Feb 05, 2020	SELL	$19.49 - $32.63 $13,623 - $22,808	-699 Reduced 4.7%	14,180 $430,000
Q3 2019 Oct 18, 2019	SELL	$22.49 - $26.81 $26,200 - $31,233	-1,165 Reduced 7.26%	14,879 $337,000
Q2 2019 Aug 01, 2019	BUY	$20.48 - $27.76 $14,336 - $19,432	700 Added 4.56%	16,044 $392,000
Q1 2019 May 15, 2019	BUY	$19.43 - $26.41 $298,133 - $405,235	15,344 New	15,344 $372,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.